References
- Andreasen PA, Kjoller L, Christensen L and Duffy MJ. 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72: 1-22. https://doi.org/10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z
- Bugge TH, Flick MJ, Daugherty CC and Dengen JL. 1995. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Gene. Dev. 9: 794-807. https://doi.org/10.1101/gad.9.7.794
- Carmeliet P and Collen D. 1996. Gene manipulation and transfer of the plasminogen and coagulation system in mice. Semin. Thromb. Hemost. 22: 525-542. https://doi.org/10.1055/s-2007-999055
- Carmeliet P, Schoonjans L, Kiechens L, Ream B, Degen J, Bronson R, De VR, Van DOJJ, Collen D and Mulligan RC. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368: 419-424. https://doi.org/10.1038/368419a0
- Casslen B, Nordengren J, Gustavsson B, Nilbert M and Lund LR. 1995. Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor. J. Clin. Endocrinol. Metab. 80: 2776-2784.
- EstelleA JG, EstelleA A, Gilabert J, CastelloA R, EspanA F, Falco C, Romeu A, Chirivella M, Zorio E and Aznar J. 2003. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum. Reprod. 18: 1516-1522. https://doi.org/10.1093/humrep/deg300
- Feng Q, Liu K, Hu ZY, Zou RJ, Yang SC and Liu YX. 1993. Possible involvement of tissue-type plasminogen activator in luteolysis of rhesus monkeys. Hum. Reprod. 8: 1640-1644. https://doi.org/10.1093/oxfordjournals.humrep.a137905
- Finn CA. 1986. Implantation, menstruation and inflammation. Biol. Rev. 61: 313-328. https://doi.org/10.1111/j.1469-185X.1986.tb00657.x
- Gunzler WA, Steffens GJ, Otting F, Kim SM, Frankus E and Flohe L. 1982. The primary structure of high molecular mass urokinase from human urine: the complete amino acid sequence of the chain. Hoppe Seyler's. Z. Physiol. Chem. 363: 1155-1165. https://doi.org/10.1515/bchm2.1982.363.2.1155
- Hu ZY, Liu YX, Liu K, Byrne S, Ny T, Feng Q and Ockleford CD. 1999. Expression of tissue-type and urokinase-type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. J. Anat. 194: 183-195. https://doi.org/10.1046/j.1469-7580.1999.19420183.x
- Irigoyen JP, Canoves PM, Montero L, Koziczak M and Nagamine Y. 1999. The plasminogen activator system: biology and regulation. Cell. Mol. Life Sci. 56: 104-132. https://doi.org/10.1007/PL00000615
- Johnson GA, Bazer FW, Burghardt RC, Spencer TE, Wu G and Bayless KJ. 2009. Conceptus-uterus interactions in pigs: endometrial gene expression in response to estrogens and interferons from conceptuses. Soc. Reprod. Fertil. Suppl. 66: 321-332.
- Ka H, Jaeger LA, Johnson GA, Spencer TE and Bazer FW. 2001. Keratinocyte growth factor is up-regulated by estrogen in the porcine uterine endometrium and functions in trophectoderm cell proliferation and differentiation. Endocrinology 142: 2303-2310. https://doi.org/10.1210/endo.142.6.8194
- Kim KH, Lee YS, Gu HN, Yang BK, Cheong HT and Park CK. 2011. Changes in plasminogen activity in uterus tissue during the estrous cycle in the pigs. Reprod. Dev. Biol. 35: 463-468
- Koh SCL, Wong PC, Yuen R, Chua SE, Ng BL and Ratnam SS. 1992. Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle. J. Reprod. Fertil. 96: 407-413. https://doi.org/10.1530/jrf.0.0960407
- Lai MD, Lee LR, Cheng KS and Wing LYC. 2000. Expression of proliferating cell nuclear antigen in luminal epithelium during the growth and regression of rat uterus. J. Endocrinol. 166: 87-93. https://doi.org/10.1677/joe.0.1660087
- Lijnen HR and Collen D. 1982. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin. Semin. Thromb. Hemost. 8: 2-10. https://doi.org/10.1055/s-2007-1005038
- Littlefield BA. 1991. Plasminogen activators in endometrial physiology and embryo implantation: a review. Ann. N.Y. Acad. Sci. 622: 167-175. https://doi.org/10.1111/j.1749-6632.1991.tb37860.x
- Liu K, Brandstrom A, Liu YX, Ny T and Selstam G. 1996. Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat. Endocrinology 137: 2126-2132. https://doi.org/10.1210/endo.137.5.8612557
- Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C and Ockleford CD. 1998. Localisation and distribution of tissue-type and urokinase-type plasminogen activators and their inhibitors type-1 and type-2 in human and rhesus monkey fetal membranes. J. Anat. 194: 183-195.
- Liu YX, Peng XR and Ny T. 1991. Tissue-specific and timecoordinated hormone regulation of plasminogen-activatorinhibitor type-1 and tissue-type plasminogen activator during gonadotrophin induced ovulation. Eur. J. Biochem. 195: 549-555. https://doi.org/10.1111/j.1432-1033.1991.tb15736.x
- Martin O and Arias F. 1982. Plasminogen activator production by trophoblast cells in vitro effect of steroid hormones and protein synthesis inhibitors. Am. J. Obstet. Gynecol. 142: 402-409. https://doi.org/10.1016/S0002-9378(16)32380-8
- Menshikov M, Plekhanova O, Cai H, Chalupsky K, Parfyonova Y, Bashtrikov P, Tkachuk V and Berk BC. 2006. Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via Redox-Dependent pathways. Arterioscler. Thromb. Vasc. Biol. 26: 801-807. https://doi.org/10.1161/01.ATV.0000207277.27432.15
- Mignatti P and Rifkin DB. 1993. Biology and biochemistry of proteinase in tumor invasion. Physiol. Rev. 73: 161-195. https://doi.org/10.1152/physrev.1993.73.1.161
- Mullins DE, Bazer FW and Roberts RM. 1980. Secretion of a progesterone-induced inhibitor of plasminogen activator by the porcine uterus. Cell. 20: 865-872. https://doi.org/10.1016/0092-8674(80)90333-5
- Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K and Eriksson U. 1998. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl. Acad. Sci. USA 95: 11709-11714. https://doi.org/10.1073/pnas.95.20.11709
- Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA and Ward CA. 1983. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301: 214-221. https://doi.org/10.1038/301214a0
- Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF and Collen D. 1995. Effects of disruption of the plasminogen gene on thrombosis, growth and health in mice. Circulation 1: 2585-2593.
- Reich E. 1978. Activation of plasminogen: a general mechanism for producing localized extracellular proteolysis. In: Berlin RD, Hermann H, Lepow IH, Tanzer JM (eds.). In Molecular Basis of Biological Degradative Processes. Acad Press, Inc., NY. pp 155-169.
- Sappino AP, Huarte J, Belin D and Vassalli JD. 1989. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J. Cell Biol. 109: 2471-2479. https://doi.org/10.1083/jcb.109.5.2471
- Stepanova V, Mukhina S, Köler E, Resink TJ, Erne P and Tkachuk VA. 1999. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysisdependent mechanisms. Mol. Cell. Biochem. 195: 199-206. https://doi.org/10.1023/A:1006936623106
- Stroband HWJ, Taverne N, Langenfeld K and Barends PMG. 1986. The ultrastructure of the uterine epithelium of the pig during the estrous cycle and early pregnancy. Cell Tissue Res. 246: 81-89.
- Tabibzadeh S. 1996. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodeling. Mol. Hum. Reprod. 2: 77-92. https://doi.org/10.1093/molehr/2.2.77
-
Tanikawa M, Kim TS, Okuda K, Ryoo ZY, Park SB, Shin JH, Park CK and Lee DS. 2009. Cell-type specificity of interleukins
$1{\alpha}$ and$1{\beta}$ on prostaglandin and plasminogen activator production in bovine endometrial cells. Anim. Reprod. Sci. 114: 32-42. https://doi.org/10.1016/j.anireprosci.2008.09.003 - Teesalu T, Blasi F and Talarico D. 1996. Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and _2MR/LRP genes. Mech. Develop. 56: 103-116. https://doi.org/10.1016/0925-4773(96)00515-1
- Ueyama M, Kasatori N, Urayama T, Maemura T, Yao Y, Shiraishi T, Saito S and Kubo H. 2002. Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblasts. Thromb. Res. 108: 235-244. https://doi.org/10.1016/S0049-3848(03)00029-X
- Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331. https://doi.org/10.1126/science.270.5240.1326